CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the launch of the EZValidation Online Tool, which helps clinical laboratories standardize their verification and validation requirements and eases adoption of new molecular tests for labs in the United States and Europe.

Life Technologies’ EZValidation Online Toolis a web-based program designed to assist laboratories in identifying molecular assay verification or validation requirements to comply with CLIA (Clinical Laboratory Improvement Amendments) accreditation requirements in the U.S. and meet ISO standards in Europe. Compliance with CLIA requirements is necessary for any laboratory that reports patient results for clinical purposes in the United States.

Specifically, the program helps laboratories identify verification and validation steps required to implement new molecular tests. The performance and accuracy of molecular tests is enhanced through the use of well-characterized quality control materials.

The EZValidation Online Tool, which may be configured to work with Life Technologies’ AcroMetrix quality control materials, helps labs establish an easy-to-use workflow from protocol development through the final report generation. The tool provides a simplified path for adopting new molecular assays through ISO 15189, CLIA, CAP (College of American Pathologists) and New York State guidelines. The online tool is also updateable for new guidelines and tests as they are developed.

“EZValidation’s Online Tool will help clinical labs maintain their compliance and adopt new molecular tests to foster the accuracy, reliability and timeliness of patients’ results,” said Kimberlee Caple, Head of Molecular Medicine Products at Life Technologies. “The clinical laboratory market is the front line for the adoption of molecular medicine in healthcare, and EZValidation helps those facilities incorporate molecular assays more efficiently, accurately and effectively.”

Life Technologies holds a significant portfolio of molecular diagnostics products that comprise more than $300 million of the company’s revenue, including components such as AcroMetrix quality control products, magnetic beads, fluorescent dyes and specific antibodies.

Life Technologies’ EZValidation Online Tool is available at http://labqc.appliedbiosystems.com.

About Life Technologies

Life Technologies (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetech.com/home.html.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

The EZValidation Online Tool is a web-based program intended to assist laboratories meet their verification or validation requirements. Laboratories are responsible for ensuring compliance with applicable international, national and local clinical laboratory regulations and specific accreditation requirements.

SOURCE: Life Technologies Corporation